Pulmonary adenoma and endocrine cell hyperplasia in Syrian golden hamster treated with 4-nitroquinoline 1-oxide.
Chronic effects of 4-nitroquinoline 1-oxide (4 NQO) on the lungs of Syrian golden hamsters were studied. 4 NQO was subcutaneously injected weekly for 3 weeks at a dose of 20 mg/kg body weight. The animals were sacrificed at the 65th and 80th experimental weeks. Two cases of pulmonary adenomas were demonstrated in the 10 4 NQO-treated animals at the 80th week, and the tumor cells contained cytoplasmic lamellar inclusion bodies. In a previous study, we reported 4 NQO- induced pulmonary endocrine cell hyperplasias in the 4 NQO-treated hamster after the 20th experimental week (Jpn. J. Cancer Res., 77, 1986). In the present study, 12 pulmonary endocrine cell hyperplasias were recognized in serial sections of the 24 treated animals. The hyperplastic lesions showed positive immunoreactivity to calcitonin. The hyperplastic lesion did not develop to pulmonary endocrine cell neoplasm.
Ito
T
T
Department of Pathology, Yokohama City University, School of Medicine, Japan.
Kitamura
H
H
Inayama
Y
Y
Kanisawa
M
M
D015112:4-Nitroquinoline-1-oxide / Q000494:pharmacology; D000236:Adenoma / Q000139:chemically induced / Q000473:pathology*; D000818:Animals; D006224:Cricetinae; D004195:Disease Models, Animal; D004702:Endocrine Glands / Q000473:pathology*; D006965:Hyperplasia / Q000473:pathology / Q000662:veterinary; D008175:Lung Neoplasms / Q000139:chemically induced / Q000473:pathology*; D008297:Male; D008647:Mesocricetus
D015112:4-Nitroquinoline-1-oxide